Literature DB >> 131175

Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

L Shou, S A Schwartz, R A Good.   

Abstract

Pretreatment of normal human peripheral blood lymphocytes with the plant lectin, concanavalin A (Con A), results in inhibition of blast transformation and [3H]thymidine incorporation by untreated allogeneic lymphocytes from healthy volunteers donors in one-way mixed leukocyte culture. Similarly, responses to mitogens, certain microbial antigens, and allogeneic lymphocytes are inhibited by Con A-treated allogeneic cells. Con A pretreated autologous lymphocytes can also be induced to manifest suppressor activities. This antimitotic effect occurs without evidence of cytotoxicity and is active on de novo lymphocyte responses and does not require prior sensitization of the cells being tested. Suppression of the lymphocyte response to pokeweed mitogen, a potent B-cell stimulator, by Con A-pretreated suppressor cells was not as consistent as was inhibition of response to other mitogens, including phytohemagglutinin and Con A. Furthermore, suppression of lymphocyte transformation to the microbial antigens, tuberculin purified protein derivative, and Canadida albicans extracts could be similarly induced by Con A pretreatment of either allogeneic or autologous cells. Induction of autologous suppressor activity in lymphocytes from healthy donors is compatible with a model that includes a role for suppressor cells in the modulation of the normal immune response.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 131175      PMCID: PMC2190183          DOI: 10.1084/jem.143.5.1100

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro.

Authors:  D W Thomas; W K Roberts; D W Talmage
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions.

Authors:  R R Rich; S S Rich
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients.

Authors:  T Y Ha; B H Waksman
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

5.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

6.  Strain differences in the ability of antithymocyte serum (ATS) to enhance the antibody response of inbred mice to type 3 pneumococcal polysaccharide.

Authors:  D R Barthold; P W Stashak; D F Amsbaugh; B Prescott; P J Baker
Journal:  Cell Immunol       Date:  1973-02       Impact factor: 4.868

7.  Supressor cells in the graft vs host reaction.

Authors:  J A Hardin; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

8.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

9.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Antigen-antibody crossed electrophoresis (Laurell) applied to the study of the antigenic structure of Candida albicans.

Authors:  N H Axelsen
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

View more
  141 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

3.  PPD-induced blastogenesis is auto-regulated by suppressor cells generated in vitro.

Authors:  N Aoki; L J Degroot
Journal:  Experientia       Date:  1979-11-15

4.  Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.

Authors:  J B Innes; M M Kuntz; Y T Kim; M E Weksler
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

5.  Colony formation by subpopulations of human T lymphocytes. I. Effects of phytohaemagglutinin and lymphocytosis-promoting factor from Bordetella pertussis.

Authors:  M H Claësson; V Andersen; G Sønderstrup-Hansen
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

6.  The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge.

Authors:  N W Brattig; G J Diao; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Authors:  R L Gonzalez; P C Dau; L E Spitler
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

10.  A human suppressor lymphocyte subpopulation identified by a heteroantiserum.

Authors:  A J Rizzoli; A D Bankhurst
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.